Skip to main content
. 2014 Oct 6;9(10):e109668. doi: 10.1371/journal.pone.0109668

Figure 6. 131I-CLR1404 accumulates in a patient with metastatic colon cancer.

Figure 6

As part of a phase I clinical trial, SPECT images were acquired between 6 and 21 days after administration of 131I-CLR1404. Areas of increased signal intensity corresponded to known areas of metastatic colon cancer in both lungs. Prolonged retention of this agent within these lesions was also demonstrated. T, tumor; H. heart.